NEOGEN Chemicals Limited’s Board approved the Unaudited Financial Results for the quarter and nine months ended December 31, 2025. Key highlights include strong revenue performance across both standalone and consolidated results. Furthermore, the Board granted in-principle approval to raise up to Rs. 150 crores via a preferential issue of equity shares, primarily based on intent from the Promoter Group. The Nomination and Remuneration Committee also approved a new tranche of 50,200 Stock Options under the 2024 ESOP Scheme.
Board Meeting Outcome and Financial Results
The Board of Directors of NEOGEN Chemicals Limited convened on Wednesday, February 11, 2026, considering and approving several key items, including the Unaudited Financial Results for the quarter and nine months ended December 31, 2025 (both standalone and consolidated). These results were subjected to a Limited Review by the Statutory Auditors.
Standalone Financial Performance Summary (Q3 FY26 vs. Q3 FY25)
The standalone results show a notable increase in core profitability:
- Profit before tax (PBT) for the quarter ended December 31, 2025 stood at Rs. 11.80 crores, compared to Rs. 20.05 crores for the corresponding quarter last year. (Note: The PBT for Q3 FY26 is lower than Q3 FY25 due to an Exceptional Item loss of Rs. 13.56 crores recognized in the previous year, FY25, related to the fire incident.)
- For the nine months ended December 31, 2025, PBT was Rs. 43.21 crores, up from Rs. 58.60 crores in the previous nine-month period (again influenced by exceptional items).
- Basic & Diluted Earnings Per Share (not annualized) for the quarter stood at 3.32, compared to 5.46 in Q3 FY25.
- Operating Margin stood at 17% for the quarter.
Consolidated Financial Performance Summary (Q3 FY26 vs. Q3 FY25)
The consolidated figures reflect the Group’s performance:
- Consolidated Profit before tax (PBT) for the quarter was Rs. 5.76 crores, against Rs. 15.25 crores in Q3 FY25 (which included a net exceptional gain of Rs. 14.08 crores in the prior period).
- For the nine months ended December 31, 2025, consolidated PBT was Rs. 25.20 crores, compared to Rs. 46.48 crores previously.
- Basic & Diluted EPS (not annualized) for the quarter was 1.40, against 3.80 in Q3 FY25.
- The Consolidated Operating Margin for the quarter was 15%.
Approval for Fund Raising
The Board granted in-principle approval for raising capital up to an aggregate amount of Rs. 150 crores (including premium) through a preferential issue of equity shares. This proposal is based on the intent received from the Promoter Group and remains subject to necessary regulatory approvals.
Employee Stock Option Plan Update
The Nomination and Remuneration Committee (NRC) approved the grant of 50,200 Stock Options under the “NCL ESOP Scheme 2024” (Tranche-II Grant) to 55 Eligible Employees. Additionally, the NRC approved the vesting of 4,650 employee stock options granted earlier in Tranche-I, effective from April 1, 2026.
Auditors’ Remarks on Fire Incident
The auditors noted significant information regarding the March 05, 2025 fire incident at the Dahej SEZ Plant, which impacted property, plant, equipment, inventory, and business operations. On a standalone basis, the Company recognized a net loss of Rs. 13.56 crores (Loss of Rs. 348.16 crores minus Claim Receivable of Rs. 334.60 crores) presented under ‘Exceptional Items’ for the year ended March 31, 2025. The assessment of the final insurance claim is ongoing, with management having received initial payments.
Source: BSE
